Previous Article | Next Article ![]()
Appl Environ Microbiol. 1968 November; 16(11): 1753-1760
Copyright © 1968 American Society for Microbiology. All Rights Reserved.
Thorndike Memorial Laboratory, Second and Fourth (Harvard) Medical Services, Boston City Hospital, Boston, Massachusetts 02118
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02118
ABSTRACT
Carbenicillin is a new semisynthetic penicillin which differs from other penicillins in showing moderate antibacterial activity against Pseudomonas. Its activity in vitro is enhanced at low pH. Serum binding is of low order and does not appreciably alter activity. Strains of Pseudomonas exposed to subinhibitory concentrations of carbenicillin rapidly develop resistance by a mechanism that does not depend upon destruction of the drug. In normal subjects, high levels of anti-Pseudomonas activity are readily obtained in the urine after intramuscular injection. Levels of carbenicillin adequate to inhibit many strains of Pseudomonas can be achieved in serum only with an intravenous administration of a large dose. Carbenicillin appears to exhibit the same low degree of toxicity as do other penicillins.
1 Research Fellow of the Helen Hay Whitney Foundation.
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|